New England Has $9 Billion Worth of Reasons to Embrace the Pharmaceutical-Biotech Industry, an Industrial Info News Alert

Marketwired

SUGAR LAND, TX--(Marketwired - Jul 24, 2013) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- North America has nearly 1,300 active Pharmaceutical-Biotech capital and maintenance projects with a total investment value (TIV) of $57 billion. According to a recent analysis of Industrial Info's Pharmaceutical-Biotech Industry database, the New England region reigns in the top spot with a $9 billion slice of that spending.

Other companies featured: Vertex Pharmaceuticals (VRTX), Novartis (NVS)

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/news/abstract.jsp?newsitemID=236861&refer=mw, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com "Contact Us" page.

Contact:

Joe Govreau
713-783-5147

Rates

View Comments (0)